News Qiagen N.V.

Equities

Market Closed - Nyse Other stock markets 04:00:03 2024-06-21 pm EDT			5-day change	1st Jan Change
41.86 ^USD	-0.07%		-1.13%	-6.51%

Jun. 21	Qiagen Seeks M&A	CI
Jun. 21	Transcript : Qiagen N.V. - Shareholder/Analyst Call

Qiagen Seeks M&A	Jun. 21	CI
Transcript : Qiagen N.V. - Shareholder/Analyst Call	Jun. 21
Qiagen N : Stifel – European Healthcare Summit Capital Markets Day Presentation	Jun. 20	PU
Qiagen N : Stifel – European Healthcare Summit Infographic	Jun. 20	PU
Sartorius on the downswing again - low since 2020 is approaching	Jun. 19	DP
Invest Securities Raises Qiagen PT, Maintains Neutral Rating	Jun. 19	MT
UBS Raises Qiagen Price Target to $46 From $44, Maintains Neutral Rating	Jun. 18	MT
JPMorgan Raises Price Target on Qiagen to $54 From $52, Maintains Overweight Rating	Jun. 18	MT
QIAGEN NV : Gets a Neutral rating from UBS	Jun. 18	ZD
QIAGEN NV : Deutsche Bank reaffirms its Buy rating	Jun. 18	ZD
QIAGEN NV : Berenberg remains its Buy rating	Jun. 18	ZD
Frankfurt shares close: Dax recovers	Jun. 17	DP
Transcript : Qiagen N.V. - Analyst/Investor Day	Jun. 17
Dpa-AFX Overview: COMPANIES from 17.06.2024 - 15:15	Jun. 17	DP
Qiagen Targets 7% Annual Sales Growth Through 2028	Jun. 17	MT
Qiagen eyes sales growth of 7% per year until 2028	Jun. 17	RE
QIAGEN announces 2028 strategy for solid profitable growth	Jun. 17	AQ
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs	Jun. 13	AQ
QIAGEN Announces the Release of A New Version of Its Clinical Decision Support Software, QCI Interpret	Jun. 13	CI
QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth	Jun. 12	AQ

No results for this search

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 09:32 am EDT